Free Access
Med Sci (Paris)
Volume 30, Number 3, Mars 2014
Page(s) 289 - 296
Section M/S Revues
Published online 31 March 2014
  1. Swarup V, Rajeswari MR. Circulating (cell-free) nucleic acids. A promising, non-invasive tool for early detection of several human diseases. FEBS Lett 2007 ; 581 : 795–799. [CrossRef] [PubMed] [Google Scholar]
  2. Gilad S, Meiri E, Yogev Y, et al. Serum microRNAs are promising novel biomarkers. PLoS One 2008 ; 3 : 3148. [CrossRef] [PubMed] [Google Scholar]
  3. ENCODE project consortium. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project Nature 2007 ; 447 : 799–816. [CrossRef] [PubMed] [Google Scholar]
  4. Mattick JS, Makunin IV. Non-coding RNA. Hum Mol Genet 2006 ; 15 : R17–R29. [Google Scholar]
  5. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993 ; 75 : 843–854. [CrossRef] [PubMed] [Google Scholar]
  6. Wightman B, Ha I, Ruvkun G. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 1993 ; 75 : 855–62. [CrossRef] [PubMed] [Google Scholar]
  7. Filipowicz W, Bhattacharyya SN, Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?. Nat Rev Genet 2008 ; 9 : 102–114. [Google Scholar]
  8. Dunoyer P. La bataille du silence : mécanisme et inhibition du RNA silencing au cours des interactions plante/virus. Med Sci (Paris) 2009 ; 25 : 505–512. [Google Scholar]
  9. Sacco L Da, Masotti A. Recent insights and novel bioinformatics tools to understand the role of microRNAs binding to 5’ untranslated region. Int J Mol Sci 2012 ; 14 : 480–495. [CrossRef] [PubMed] [Google Scholar]
  10. Kozomara A, Griffiths-Jones S. miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res 2011 ; 39 : D152–D157. [CrossRef] [PubMed] [Google Scholar]
  11. Friedman RC, Farh KK-H, Burge CB, et al. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 2009 ; 19 : 92–105. [CrossRef] [PubMed] [Google Scholar]
  12. Ventura A, Jacks T. MicroRNAs and cancer: short RNAs go a long way. Cell 2009 ; 136 : 586–591. [CrossRef] [PubMed] [Google Scholar]
  13. Zhang Y, Liu D, Chen X, et al. Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol Cell 2010 ; 39 : 133–144. [CrossRef] [PubMed] [Google Scholar]
  14. Hergenreider E, Heydt S, Tréguer K, et al. Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nat Cell Biol 2012 ; 14 : 249–256. [CrossRef] [PubMed] [Google Scholar]
  15. Mathivanan S, Fahner CJ, Reid GE, et al. ExoCarta 2012: database of exosomal proteins, RNA and lipids. Nucleic Acids Res 2012 ; 40 : D1241–D1244. [CrossRef] [PubMed] [Google Scholar]
  16. Zernecke A, Bidzhekov K, Noels H, et al. Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci Signal 2009 ; 2 : ra81. [CrossRef] [PubMed] [Google Scholar]
  17. Vickers KC, Palmisano BT, Shoucri BM, et al. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol 2011 ; 13 : 423–433. [CrossRef] [PubMed] [Google Scholar]
  18. Arroyo JD, Chevillet JR, Kroh EM, et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci USA 2011 ; 108 : 5003–5008. [CrossRef] [Google Scholar]
  19. Turchinovich A, Weiz L, Langheinz A, et al. Characterization of extracellular circulating microRNA. Nucleic Acids Res 2011 ; 39 : 7223–7233. [CrossRef] [PubMed] [Google Scholar]
  20. Russo F, Bella S Di, Nigita G, et al. miRandola: extracellular circulating microRNAs database. PLoS One 2012 ; 7 : e47786. [CrossRef] [PubMed] [Google Scholar]
  21. Weber JA, Baxter DH, Zhang S, et al. The microRNA spectrum in 12 body fluids. Clin Chem 2010 ; 56 : 1733–1741. [CrossRef] [PubMed] [Google Scholar]
  22. Laterza OF, Lim L, Garrett-Engele PW, et al. Plasma microRNAs as sensitive and specific biomarkers of tissue injury. Clin Chem 2009 ; 55 : 1977–1983. [CrossRef] [PubMed] [Google Scholar]
  23. Montecalvo A, Larregina AT, Shufesky WJ, et al. Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes. Blood 2012 ; 119 : 756–766. [CrossRef] [PubMed] [Google Scholar]
  24. Tréguer K, Heydt S, Hergenreider E. Protection des vaisseaux sanguins contre l’athérosclérose : le rôle des miARN sécrétés par l’endothélium. Med Sci (Paris) 2012 ; 28 : 584–587. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  25. Kogure T, Lin W-L, Yan IK, et al. Inter-cellular nanovesicle mediated microRNA transfer: a mechanism of environmental modulation of hepatocellular cancer cell growth. Hepatology 2011 ; 54 : 1237–1248. [CrossRef] [PubMed] [Google Scholar]
  26. Fabbri M, Paone A, Calore F, et al. MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response. Proc Natl Acad Sci USA 2012 ; 109 : E2110–E2116. [CrossRef] [Google Scholar]
  27. Lawrie CH, Gal S, Dunlop HM, et al. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol 2008 ; 141 : 672–675. [CrossRef] [PubMed] [Google Scholar]
  28. Guire V De, Robitaille R, Tétreault N, et al. Circulating miRNAs as sensitive and specific biomarkers for the diagnosis and monitoring of human diseases: promises and challenges. Clin Biochem 2013 ; 46 : 846–60. [CrossRef] [PubMed] [Google Scholar]
  29. Corsten MF, Dennert R, Jochems S, et al. Circulating microRNA-208b and microRNA-499 reflect myocardial damage in cardiovascular disease. Circ Cardiovasc Genet 2010 ; 3 : 499–506. [CrossRef] [PubMed] [Google Scholar]
  30. Cermelli S, Ruggieri A, Marrero JA, et al. Circulating microRNAs in patients with chronic hepatitis C, non-alcoholic fatty liver disease. PLoS One 2011 ; 6 : e23937. [CrossRef] [PubMed] [Google Scholar]
  31. Zampetaki A, Kiechl S, Drozdov I, et al. Plasma microRNA profiling reveals loss of endothelial MiR-126 and other microRNAs in type 2 diabetes. Circ Res 2010 ; 107 : 810–817. [CrossRef] [PubMed] [Google Scholar]
  32. Gilad S, Lithwick-Yanai G, Barshack I, et al. Classification of the four main types of lung cancer using a microRNA-based diagnostic assay. J Mol Diagn 2012 ; 14 : 510–517. [CrossRef] [PubMed] [Google Scholar]
  33. Chen X, Hu Z, Wang W, et al. Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis. Int J Cancer 2012 ; 130 : 1620–1628. [CrossRef] [PubMed] [Google Scholar]
  34. Heneghan HM, Miller N, Kerin MJ, Circulating microRNAs: promising breast cancer biomarkers. Breast Cancer Res 2011 ; 13 : 402. [CrossRef] [PubMed] [Google Scholar]
  35. Huang Z, Huang D, Ni S, et al. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer 2010 ; 127 : 118–126. [CrossRef] [PubMed] [Google Scholar]
  36. Liu J, Gao J, Du Y, et al. Combination of plasma microRNAs with serum CA19–9 for early detection of pancreatic cancer. Int J Cancer 2012 ; 131 : 683–691. [CrossRef] [PubMed] [Google Scholar]
  37. Scian M, Maluf D, David K, et al. MicroRNA profiles in allograft tissues and paired urines associate with chronic allograft dysfunction with IF/TA. Am J Transplant 2011 ; 11 : 2110–2112. [CrossRef] [PubMed] [Google Scholar]
  38. Hinault C, Dumortier O, Van Obberghen E. MicroARN et diabète : petites structures, grands effets. Med Sci (Paris) 2013 ; 29 : 785–790. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  39. Bournet B, Dufresne M, Selves J, et al. Oncogène Kras et cancer du pancréas : trente ans plus tard. Med Sci (Paris) 2013 ; 29 : 991–997. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.